Pages that link to "Q60452032"
Jump to navigation
Jump to search
The following pages link to Development of small molecule probes for the Beta-amyloid protein of Alzheimer's Disease (Q60452032):
Displaying 50 items.
- Proteins behaving badly. Substoichiometric molecular control and amplification of the initiation and nature of amyloid fibril formation: lessons from and for blood clotting (Q26739684) (← links)
- Dye-binding assays for evaluation of the effects of small molecule inhibitors on amyloid (aβ) self-assembly (Q26852205) (← links)
- Development of positron emission tomography β-amyloid plaque imaging agents (Q27012742) (← links)
- The fluorescent Congo red derivative, (trans, trans)-1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene (BSB), labels diverse beta-pleated sheet structures in postmortem human neurodegenerative disease brains (Q28350692) (← links)
- Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils-current status (Q28393352) (← links)
- A chemical analog of curcumin as an improved inhibitor of amyloid Abeta oligomerization (Q28481562) (← links)
- Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice (Q30481038) (← links)
- In vivo amyloid imaging in Alzheimer's disease (Q30889969) (← links)
- PET imaging of amyloid in Alzheimer's disease. (Q30953216) (← links)
- Anti-Amyloid Effects of Small Molecule Aβ-Binding Agents in PS1/APP Mice (Q33616714) (← links)
- Approaches to discovery and characterization of inhibitors of amyloid beta-peptide polymerization (Q33971304) (← links)
- A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain (Q34111636) (← links)
- Imaging of CNS myelin by positron-emission tomography (Q34695082) (← links)
- Insight into Amyloid Structure Using Chemical Probes (Q34990429) (← links)
- Aspartic proteases involved in Alzheimer's disease (Q35125093) (← links)
- In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease (Q35164211) (← links)
- Imaging the pathology of Alzheimer's disease: amyloid-imaging with positron emission tomography (Q35692953) (← links)
- Mechanistic insights into the cure of prion disease by novel antiprion compounds (Q36099134) (← links)
- Liver transplantation and new therapeutic approaches for familial amyloidotic polyneuropathy (FAP). (Q36260660) (← links)
- Ligand electronic properties modulate tau filament binding site density (Q36368413) (← links)
- Quantitative thermophoretic study of disease-related protein aggregates (Q36694459) (← links)
- Development and evaluation of compounds for imaging of beta-amyloid plaque by means of positron emission tomography (Q37068771) (← links)
- A review of imaging agent development (Q37214528) (← links)
- Small-molecule theranostic probes: a promising future in neurodegenerative diseases. (Q37353880) (← links)
- Interactions between Microtubule-Associated Protein Tau (MAPT) and Small Molecules (Q39035486) (← links)
- Chrysamine G and its derivative reduce amyloid beta-induced neurotoxicity in mice (Q39095755) (← links)
- Effects of Congo red on aβ(1-40) fibril formation process and morphology (Q39287470) (← links)
- Exploring Anti-Prion Glyco-Based and Aromatic Scaffolds: A Chemical Strategy for the Quality of Life. (Q39326827) (← links)
- Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. (Q40415499) (← links)
- A spectroscopic study of 2-[4'-(dimethylamino)phenyl]-benzothiazole binding to insulin amyloid fibrils (Q43142184) (← links)
- 4,4(')-Dianilino-1,1(')-binaphthyl-5,5(')-disulfonate: report on non-beta-sheet conformers of Alzheimer's peptide beta(1-40). (Q44070739) (← links)
- Synthesis and evaluation of 2-(3'-iodo-4'-aminophenyl)-6-hydroxybenzothiazole for in vivo quantitation of amyloid deposits in Alzheimer's disease (Q44125937) (← links)
- The binding of 2-(4'-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component. (Q44376543) (← links)
- Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients (Q44381630) (← links)
- Dimethylamino-fluorenes: ligands for detecting beta-amyloid plaques in the brain (Q44538100) (← links)
- Effects of lipophilicity on the affinity and nonspecific binding of iodinated benzothiazole derivatives (Q44591011) (← links)
- In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe (Q46440739) (← links)
- Quantifying amyloid by congo red spectral shift assay (Q46504553) (← links)
- Congo red populates partially unfolded states of an amyloidogenic protein to enhance aggregation and amyloid fibril formation (Q46603261) (← links)
- Chrysamine-G, a lipophilic analogue of Congo red, inhibits A beta-induced toxicity in PC12 cells (Q46636186) (← links)
- Predicting the in vitro toxicity of synthetic beta-amyloid (1-40). (Q46669801) (← links)
- A novel tool for detecting amyloid deposits in systemic amyloidosis in vitro and in vivo. (Q46679984) (← links)
- Amyloid probes based on Congo Red distinguish between fibrils comprising different peptides (Q46863294) (← links)
- Michler’s Hydrol Blue: A Sensitive Probe for Amyloid Fibril Detection (Q50278862) (← links)
- Congo red reverses amyloid β protein-induced cellular stress in astrocytes (Q50526515) (← links)
- A model for structure-dependent binding of Congo red to Alzheimer beta-amyloid fibrils. (Q52244615) (← links)
- [18] Quantification of β-sheet amyloid fibril structures with thioflavin T (Q60547063) (← links)
- Congo Red and amyloids: history and relationship (Q61447904) (← links)
- (Q64361003) (redirect page) (← links)
- Computationally derived structural models of the beta-amyloid found in Alzheimer's disease plaques and the interaction with possible aggregation inhibitors (Q73147140) (← links)